 |
methyl (2R,3S)-3-[(methylsulfonyl)amino]-2-{[(cis-4-phenylcyclohexyl)oxy]methyl}piperidine-1-carboxylate |
|---|---|
| Trade Name | |
| Orphan Indication | Narcolepsy |
| USA Market Approval | USA |
| USA Designation Date | 2017-12-19 00:00:00 |
| Sponsor | Takeda Development Center Americas, Inc.;Takeda Parkway;Deerfield, Illinois, 60015 |
